# Renal Osteodystrophy: An Individual Management Approach

> **NCT02440581** · NA · COMPLETED · sponsor: **Hartmut Malluche, MD** · enrollment: 141 (actual)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** Alendronate
- **DRUG:** Teriparatide
- **DRUG:** Cinacalcet

## Key facts

- **NCT ID:** NCT02440581
- **Lead sponsor:** Hartmut Malluche, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2023-01-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02440581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02440581, "Renal Osteodystrophy: An Individual Management Approach". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02440581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*